Maynard Um
-
-
-
-
-
-
-
Haemonetics (HAE) PT Raised to $85 at Mizuho
-
-
-
-
-
-
-
Haemonetics repays $300 million convertible notes at maturity
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Haemonetics (HAE)
-
-
-
-
-
-
-
Raymond James Downgrades Haemonetics (HAE) to Outperform, Removed from Analyst Current Favorite list
-
-
-
-
-
-
-
Haemonetics (HAE) Tops Q4 EPS by 2c, provides guidance
-
-
-
-
-
-
-
Haemonetics (HAE) Completes Sale of Whole Blood Assets to GVS, S.p.A
-
-
-
-
-
-
-
Aligos Therapeutics (ALGS) Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
-
433,572 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

